BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 30953467)

  • 1. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    Chakedis J; Beal EW; Sun S; Galo J; Chafitz A; Davidson G; Reardon J; Dillhoff M; Pawlik TM; Abdel-Misih S; Bloomston M; Schmidt CR
    J Surg Oncol; 2018 Dec; 118(7):1065-1073. PubMed ID: 30376157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
    Buisman FE; Grünhagen DJ; Homs MYV; Grootscholten C; Filipe WF; Kemeny NE; Cercek A; D'Angelica MI; Donswijk ML; van Doorn L; Emmering J; Jarnagin WR; Kingham TP; Klompenhouwer EG; Kok NFM; Kuiper MC; Moelker A; Prevoo W; Versleijen MWJ; Verhoef C; Kuhlmann KFD; Groot Koerkamp B
    Ann Surg Oncol; 2019 Dec; 26(13):4599-4607. PubMed ID: 31641947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC; Edwards MJ; McMasters KM
    Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
    Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.
    Buisman FE; Galjart B; van der Stok EP; Kemeny NE; Balachandran VP; Boerner T; Cercek A; Grünhagen DJ; Jarnagin WR; Kingham TP; Verhoef C; Koerkamp BG; D'Angelica MI
    HPB (Oxford); 2020 Sep; 22(9):1271-1279. PubMed ID: 31889627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
    Filipe WF; Meyer YM; Buisman FE; van den Braak RRJC; Galjart B; Höppener DJ; Jarnagin WR; Kemeny NE; Kingham TP; Nierop PMH; van der Stok EP; Grünhagen DJ; Vermeulen PB; Groot Koerkamp B; Verhoef C; D'Angelica MI
    Ann Surg Oncol; 2023 Dec; 30(13):7996-8005. PubMed ID: 37782413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
    Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
    Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
    BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ
    J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.
    Kemeny MM; Adak S; Gray B; Macdonald JS; Smith T; Lipsitz S; Sigurdson ER; O'Dwyer PJ; Benson AB
    J Clin Oncol; 2002 Mar; 20(6):1499-505. PubMed ID: 11896097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
    Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
    Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage regional therapy using hepatic artery infusion pump in unresectable chemotherapy resistant colorectal liver metastases.
    O'Leary MP; Wang C; Sandhu J; Malhotra GK; Thornblade LW; Lau C; Melstrom LG; Fong Y; Singh G; Fakih MG
    Am J Surg; 2022 Jun; 223(6):1151-1156. PubMed ID: 34696847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
    Ayez N; van der Stok EP; de Wilt H; Radema SA; van Hillegersberg R; Roumen RM; Vreugdenhil G; Tanis PJ; Punt CJ; Dejong CH; Jansen RL; Verheul HM; de Jong KP; Hospers GA; Klaase JM; Legdeur MC; van Meerten E; Eskens FA; van der Meer N; van der Holt B; Verhoef C; Grünhagen DJ
    BMC Cancer; 2015 Mar; 15():180. PubMed ID: 25884448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
    Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
    Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
    Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
    Walker BS; Billingsley KG; Sutton TL; Kolbeck KJ; Korngold EK; Nabavizadeh N; Dewey EN; Herzig DO; Lopez CD; Mayo SC
    J Surg Oncol; 2022 Sep; 126(3):513-522. PubMed ID: 35522249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.